Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
Relative Value
The Relative Value of one AVAH stock under the Base Case scenario is 12.72 USD. Compared to the current market price of 2.2 USD, Aveanna Healthcare Holdings Inc is Undervalued by 83%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AVAH Competitors Multiples
Aveanna Healthcare Holdings Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
419.6m USD | 0.2 | -3.1 | 13 | 14.6 | |
US |
C
|
Cigna Group
XMUN:CGN
|
96.6B EUR | 0.5 | 20.1 | 10.3 | 13.8 | |
US |
Cigna Corp
NYSE:CI
|
103.7B USD | 0.5 | 20.1 | 10.3 | 13.8 | ||
US |
CVS Health Corp
NYSE:CVS
|
86.5B USD | 0.2 | 10.4 | 8.9 | 8.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22.2B EUR | 1.1 | 44.4 | 10.4 | 24.6 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.7B USD | 1.4 | 38.6 | 11.8 | 17.7 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.3B EUR | 0.7 | -25.8 | 9.9 | 22.2 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
14.9B USD | 1.6 | 17.7 | 10.6 | 14.2 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 22 | 6.7 | 15.9 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 17.1 | 8.4 | 12.3 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |